Home Weight Loss Tips & Guides

22Aug

Ozempic® vs Zepbound® for Weight Loss: Semaglutide vs Tirzepatide Compared

By Dr. Alexander Shapsis, MD, FACS — EndoSlim Clinic NY

GLP-1 Weight Loss Medication Comparison

Contents show

Ozempic® vs Zepbound® for Weight Loss: Semaglutide vs Tirzepatide Compared

Ozempic® and Zepbound® are two of the most discussed injectable medications in weight management, but they are not the same drug and they do not have identical FDA indications.

Ozempic contains semaglutide, a GLP-1 receptor agonist. Zepbound contains tirzepatide, which activates both GIP and GLP-1 receptors. For patients primarily interested in weight loss, the comparison is more accurately semaglutide vs tirzepatide.

20.2%Tirzepatide average loss at 72 weeks

13.7%Semaglutide average loss at 72 weeks

751SURMOUNT-5 participants

WeeklyBoth injectable treatments

At a Glance

Ozempic vs Zepbound: Key Differences

Feature	Ozempic®	Zepbound®
Active ingredient	Semaglutide	Tirzepatide
Mechanism	GLP-1 receptor agonist	GIP + GLP-1 receptor agonist
Injection frequency	Once weekly	Once weekly
Brand’s primary FDA role	Type 2 diabetes	Chronic weight management
Weight-management counterpart	Wegovy®	Zepbound®
Same-ingredient diabetes brand	Ozempic®	Mounjaro®

Important terminology: Ozempic® and Wegovy® both contain semaglutide, but they have different FDA indications. Mounjaro® and Zepbound® both contain tirzepatide, but they also have different indications. For an FDA-label weight-loss comparison, Wegovy vs Zepbound is the cleaner comparison even though many patients search “Ozempic vs Zepbound.”

What Is Ozempic® (Semaglutide)?

Semaglutide activates the GLP-1 receptor and can reduce appetite and increase satiety.

Ozempic is a semaglutide injection approved for type 2 diabetes. For chronic weight management, the FDA-approved semaglutide product is Wegovy®. Patients often use “Ozempic” as a general term for semaglutide, which can make comparisons confusing.

Want deeper semaglutide research? Review the Semaglutide Statistics 2026 report for STEP trial data, weight-loss outcomes, cardiovascular research, and additional semaglutide statistics.

What Is Zepbound® (Tirzepatide)?

Tirzepatide activates both GIP and GLP-1 receptors.

Zepbound is tirzepatide for chronic weight management in eligible patients. The same active ingredient is marketed as Mounjaro® for type 2 diabetes.

Explore the tirzepatide data: See the Tirzepatide Statistics 2026 report for SURMOUNT results, Zepbound® and Mounjaro® data, and current tirzepatide research.

Head-to-Head Evidence

Zepbound vs Semaglutide: Which Helps People Lose More Weight?

The strongest comparison comes from a randomized trial that directly compared tirzepatide with semaglutide.

SURMOUNT-5: Tirzepatide vs Semaglutide

Published in the New England Journal of Medicine in 2025.

SURMOUNT-5 randomized 751 adults with obesity, or overweight with a weight-related condition, who did not have type 2 diabetes. Participants received the maximum tolerated dose of tirzepatide or semaglutide for 72 weeks.

Tirzepatide20.2%

Average body-weight reduction

Semaglutide13.7%

Average body-weight reduction

Tirzepatide also produced a greater average reduction in waist circumference: 18.4 cm compared with 13.0 cm with semaglutide. Participants taking tirzepatide were more likely to achieve weight-loss thresholds of at least 10%, 15%, 20%, and 25%.

Read the SURMOUNT-5 study in the New England Journal of Medicine.

SURMOUNT-5 tirzepatide vs semaglutide comparison showing 20.2% vs 13.7% average weight loss over 72 weeks

Why Might Tirzepatide Produce More Weight Loss?

Semaglutide activates the GLP-1 receptor. Tirzepatide activates both GIP and GLP-1 receptors. This dual incretin activity may contribute to tirzepatide’s greater average weight-loss effect in head-to-head research.

That does not mean every patient who does well on semaglutide should switch. Effectiveness must be balanced against tolerability, medical history, insurance coverage, access, and the ability to stay on treatment.

Brand Name Confusion

Ozempic vs Wegovy vs Mounjaro vs Zepbound

Ozempic®

Semaglutide

Primarily used under FDA labeling for type 2 diabetes.

Wegovy®

Semaglutide

The semaglutide brand labeled for chronic weight management.

Mounjaro®

Tirzepatide

The tirzepatide brand labeled for type 2 diabetes.

Zepbound®

Tirzepatide

The tirzepatide brand labeled for chronic weight management.

Ozempic vs Zepbound Side Effects

Both medications commonly cause gastrointestinal symptoms, especially during dose escalation. These may include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, and reduced appetite.

For practical physician-guided strategies, read How to Prevent Ozempic® & Wegovy® Side Effects: Dr. Shapsis’ Tips.

Both also carry important warnings and contraindications. A clinician should review your medical history, other medications, pregnancy plans, gastrointestinal history, and thyroid-related risk factors before prescribing.

Can You Switch From Ozempic to Zepbound?

Some patients transition from semaglutide to tirzepatide because of inadequate weight loss, side effects, insurance changes, availability, or changing treatment goals.

The medications are not dose-equivalent. Do not convert milligrams yourself. The timing and starting dose after a switch should be determined by the prescribing clinician.

Can You Take Ozempic and Zepbound Together?

Using semaglutide and tirzepatide together is generally not recommended. They affect overlapping incretin pathways. If you are transitioning between therapies, follow your prescriber’s instructions rather than overlapping them yourself.

What Happens When Weight Loss Slows?

As body weight decreases, hunger may increase, fullness signals can change, and energy expenditure may fall. These adaptations can contribute to a plateau even when treatment initially worked well.

Read Why Your Body Fights Weight Loss and How Much Weight Can You Lose in 6 Months? for more detail.

What Happens When You Stop Ozempic® or Zepbound®?

Planning for maintenance matters before medication is discontinued.

For some patients, appetite increases after GLP-1 treatment is stopped and weight regain can occur over time. That does not mean treatment “failed.” Obesity is a chronic condition, and the biological pressures affecting appetite and body weight can return when treatment is removed.

Read What Happens When You Stop Taking Ozempic®? for a detailed explanation of appetite and weight regain after semaglutide.

If you are taking tirzepatide, see our guide to avoiding weight gain after Zepbound®.

For a deeper explanation of why the body can resist weight loss and defend a previous weight, read Why Your Body Fights Weight Loss.

Beyond Medication

What If You Do Not Want to Stay on Weight-Loss Injections?

For some patients, the bigger question is medication vs a gastric balloon vs ESG—not simply Ozempic vs Zepbound.

GLP-1 Medication

Physician-supervised semaglutide or tirzepatide may be appropriate for eligible patients who prefer medication-based treatment.

Allurion® Smart Capsule

A swallowable gastric balloon may provide temporary portion-control support without traditional surgery or endoscopic placement.

Orbera® Gastric Balloon

An endoscopically placed temporary gastric balloon can support smaller portions as part of a structured program.

Endoscopic Sleeve Gastroplasty

ESG uses internal sutures to reduce functional stomach volume without external abdominal incisions.

Ozempic®, Wegovy® & Semaglutide

Explore physician-supervised semaglutide care.

Mounjaro® & Zepbound® Tirzepatide

Explore physician-supervised tirzepatide weight-loss care at EndoSlim Clinic NY.

Allurion® Smart Capsule

Learn about the swallowable gastric balloon.

Orbera® Gastric Balloon

Explore temporary gastric balloon therapy.

Endoscopic Sleeve Gastroplasty (ESG)

Explore incisionless endoscopic stomach-volume reduction.

Frequently Asked Questions

Ozempic vs Zepbound FAQ

These are some of the most common questions patients ask when comparing semaglutide and tirzepatide for weight loss.

1. Is Zepbound better than Ozempic for weight loss?

In head-to-head obesity research, tirzepatide produced greater average weight loss than semaglutide. However, “better” depends on the individual patient. Medical history, diabetes status, previous GLP-1 treatment, side effects, insurance coverage, medication access, and long-term goals all matter. Also remember that Ozempic® is primarily a diabetes brand, while Wegovy® is the semaglutide brand approved for chronic weight management.

2. Which causes more weight loss: semaglutide or tirzepatide?

In the SURMOUNT-5 head-to-head trial, adults with obesity or overweight without diabetes lost an average of 20.2% of body weight with tirzepatide compared with 13.7% with semaglutide at 72 weeks. Individual results can vary considerably, and trial averages do not predict exactly how much one person will lose.

3. How long does it take to start losing weight on Zepbound?

Some patients notice appetite changes and early weight loss within the first several weeks, while others need more time as the dose is gradually increased. Weight loss is rarely linear. Your starting weight, dose, nutrition, activity, medical conditions, and individual response all influence how quickly progress appears.

4. Why am I not losing weight on Ozempic?

Early weight loss can vary widely. Some patients need more time to reach a therapeutic dose, while others may be affected by calorie intake, metabolic adaptation, sleep, medications, hormonal factors, or other medical conditions. If you are taking semaglutide and seeing little or no progress, your treatment plan should be reviewed rather than simply increasing the dose on your own.

5. What should I do if Ozempic stops working or I hit a plateau?

Plateaus are common because the body adapts as weight decreases. Hunger may increase, fullness signals may change, and energy expenditure may fall. Dr. Shapsis may review your dose, eating pattern, activity, body composition, and whether another treatment strategy makes sense. Read Why Your Body Fights Weight Loss for a deeper explanation.

6. Can Zepbound work if Ozempic did not work for me?

Possibly. Tirzepatide works through both GIP and GLP-1 pathways, while semaglutide works through GLP-1 alone. Some patients who have an inadequate response to semaglutide may respond differently to tirzepatide. That does not guarantee better results, and any switch should be medically supervised.

7. Can I switch from Ozempic to Zepbound?

Yes, some patients transition from semaglutide to tirzepatide because of limited weight loss, side effects, insurance changes, medication availability, or changing goals. The medications are not dose-equivalent, so the timing and starting dose should be determined by your prescriber. Learn more about Zepbound® and Mounjaro® tirzepatide treatment.

8. Which has more side effects: Ozempic or Zepbound?

Both can cause gastrointestinal side effects such as nausea, diarrhea, constipation, vomiting, abdominal discomfort, and reduced appetite, especially during dose escalation. There is no single medication that is easier for everyone to tolerate. For practical tips, see Dr. Shapsis’ guide to reducing Ozempic® and Wegovy® side effects.

9. What happens when you stop Ozempic or Zepbound?

Appetite can increase after treatment stops, and some patients regain part of the weight they lost. This is one reason maintenance planning is important before discontinuation. Read What Happens When You Stop Taking Ozempic®? for more detail.

10. Will I regain weight after stopping Zepbound?

Weight regain can occur after tirzepatide is discontinued, particularly if appetite returns and there is no maintenance strategy in place. Nutrition, activity, behavioral support, medical follow-up, and in some cases continued or alternative treatment may help. See our guide to avoiding weight gain after Zepbound®.

11. Do I have to take Ozempic or Zepbound for life?

Not every patient follows the same long-term plan. Obesity is a chronic condition, so some patients may benefit from continued medication, while others may transition to another maintenance strategy. The decision should be individualized based on weight response, appetite, metabolic health, side effects, cost, and the risk of regain.

12. Which is better if I do not have diabetes: Zepbound or Wegovy?

Both Zepbound® and Wegovy® are FDA-approved for chronic weight management in eligible patients, including many people who do not have diabetes. Head-to-head research has shown greater average weight loss with tirzepatide than semaglutide, but medication choice should still be individualized. Patients can also review semaglutide treatment and tirzepatide treatment at EndoSlim Clinic NY.

Dr. Alexander Shapsis at EndoSlim Clinic NY for a physician-guided weight loss consultation

Ozempic, Zepbound—or a Different Weight Loss Approach?

At EndoSlim Clinic NY, Dr. Alexander Shapsis can review your weight history, previous GLP-1 use, medical conditions, side effects, goals, and long-term preferences to determine which approach may be appropriate.

Schedule a Consultation

Trusted Sources & Further Reading

Get Started

Book an appointment and take the first step in your weight loss journey.

Book Now

Our Services